Amgen

Open: 266.33 Close: 265.02 Change: -1.31

How to get informed about Amgen Stock quickly using an AI.

This document will help you to evaluate Amgen without reading an infinite amount of sources. Relying only on stock quotes or prices to make investment decisions is a mistake. Analyzing and observing stock charts, highs and lows and other numerical data does not allow to evaluate the real value of a company. Stock quotes and prices are the result of underlying characteristics of a company and of events and news happening around them. For this reason, investing must be based on information, not numbers. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, patient, Amgens, value, Inc, cover, and the …

Concept Map

Semantic Network

Stock Summary

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. The company's products include Enbrel, Prolia, Xgeva, Otezla, Aranesp, and Repatha..

Today's Summary

Amgen (NASDAQ:AMGN) is now the time to put amgen (nasdaq:amgn) on your watchlist? Amgen is a biotechnology company, which discovers, develops, manufactures, and markets innovative human medicines to treat patients suffering from serious diseases. The current Amgen stock price $265.02 has increased 20.12% from its 52-week low.

Today's News

Amgen Inc. (AMGN) Stock Price Today, quote & news | Seeking Alpha. Company Profile Amgen is a biotechnology company, which discovers, develops, manufactures, and markets innovative human medicines to treat patients suffering from serious diseases. Amgen (NASDAQ:AMGN) is now the time to put amgen (nasdaq:amgn) on your watchlist? Is Now The Time To Put Amgen on Your Watchlist? Amgen (nasdaq:amgn) now covered by stocknews.com - defense world.com. Morgan Stanley increased its holdings in Amgen by an impressive 12.9% during the fourth quarter. Moneta Group Investment Advisors LLC witnessed the most astounding surge in its position in Amgens with an astonishing rise of 83,875.6%. Norges Bank have made headlines themselves for making an astute purchase as they acquired a new position in the Amgen stock. Quality Assurance Specialist will ensure quality and compliance are built into fundamental processes for Amgens new facility, in North Carolina (ANC) The FleX Batch facility will feature the best in-class drug substance manufacturing technologies. Amgen Inc (NASDAQ:AMGN) stock appears to be fairly valued at its current price of $261.97 per share. Amgen stock is believed to be valued to be a fairly valued company. Amgen (NASDAQ:AMGN) stock appears to be fairly valued. The current Amgen stock price $265.02 has increased 20.12% from its 52-week low. Amgen has been profitable over the past 10 years. Amgen patents covered engineered antibodies that help reduce levels of low-density lipoprotein (LDL) cholesterol, sometimes called bad cholesterol. Sanofi argued that Amgens relevant claims were invalid. Scott+Scott Attorneys at Law LLP is investigating whether certain directors and officers of Amgen Inc. breached their fiduciary duties to Amgen and its shareholders. Scott+Scott is investigating members of Amgens board of directors or senior management failed to manage Amgen in an acceptable manner. Amgen stock is fully valued after a 17% rise in a month. Compared to the current market price of 265.02 USD , Amgen Inc is Overvalued by 24%. Amgen stock has seen a 17% rise in a month, outperforming the broader S&P500 index, up 1%. Revenue per share metric has risen 6% to $49.70 now, compared to $46.90 in 2021. By clicking the I agree button, I am electronically indicating that I have read and understood Amgens Patient Authorization (above in its full text) The Amgen SupportPlus Co-Pay Card is open to patients with commercial insurance that covers an Amgen supportPlus product, regardless of financial need. Amgen SupportPlus Co-Pay Card covers eligible out-of-pocket medication costs for the Amgen supportPlus product (co-pay, deductible, or co-insurance) on behalf of the patient. Amgen Nurse Partners are available to patients who have enrolled in support from ENBREL. Patients may continue in the program as long as patient re-enrolls as required by Amgen.

Stock Profile

"Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-related events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behçet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California."

Keywords

The game is changing. There is a new strategy to evaluate Amgen fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Amgen are: Amgen, stock, patient, Amgens, value, Inc, cover, and the most common words in the summary are: amgen, job, stock, year, company, patient, share, . One of the sentences in the summary was: The current Amgen stock price $265.02 has increased 20.12% from its 52-week low.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #amgen #job #stock #year #company #patient #share.